071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and...
Transcript of 071 - Mone.Adams.Kotis - Advancing Innovation final ...€¦ · has attained the credentials and...
9/1/2017
1
Advancing Innovation in Pharmacy Practice:
Working at the Top of Our Licenses
Michael A. Moné, BSPharm, JD, FAPhA
Alex Adams, Pharm.D., MPH
Desi Kotis, Pharm.D., FASHP
Michael Moné discloses that he is on the Board of ACPE
All conflicts resolved through peer review
Michael A. Moné, BSPharm, JD, FAPhA
Objectives: Pharmacist Participants
• Explain the value that pharmacists and pharmacy technicians bring to both the profession and the public when they work at the top of their licenses.
• Describe recent innovations in pharmacist care
• List current barriers in state pharmacy practice acts that prevent expanded pharmacist care
• Discuss the expanded use of pharmacy technicians in hospitals and health‐systems
• Identify opportunities to expand pharmacist care
Objectives: Technician Participants
• Explain the value that pharmacists and pharmacy technicians bring to both the profession and the public when they work at the top of their licenses.
• Describe recent innovations in pharmacist care
• List current barriers in state pharmacy practice acts that prevent expanded pharmacist care
• Discuss the expanded use of pharmacy technicians in hospitals and health‐systems
• Identify opportunities to expand pharmacist care
Expectation
• Section 465.002, Florida Statutes: Legislative findings; intent.—The Legislature finds that the practice of pharmacy is a learned profession.
• 225 ILCS 85/1: The Practice of the Profession of Pharmacy in the State of Illinois is declared a professional practice affecting the public health, safety and welfare….practice of pharmacy, merit and receive the confidence of the public….
• Learned Profession: three historical professions… law, theology, medicine
Value PropositionWhy do we have pharmacists?
9/1/2017
2
Statutory Responsibilities
• Distill down the MUST obligations:• Accurate dispensing
• What are the elements that are MUST obligations• Product accuracy?
• Patient counseling• What are the elements that are MUST obligations
• Offer state?
• The ultimate question: Is the practice of the pharmacy a profession?• What professional standard is applied to pharmacist practice?
Statutory/Regulatory Obligations
• How to practice at the top of the license?• Reduce the statutory and regulatory obligations that are not “value add” to the public
• Reduce the misperception within the profession of what is essential to meet the statutory/regulatory obligations to the public
• Empower pharmacy technicians who have demonstrated knowledge, experience and competence with tasks that do not involve clinical decision‐making, i.e. execution
• Shift obligations to the permit that are not clinical, i.e. remove the statutory/regulatory obligations from the PIC/PDM
Achievement of Value Proposition
• New Statutory/Regulatory Paradigm• For Pharmacists – the Negligence Standard
• What would a reasonably prudent pharmacist do under similar conditions and circumstances? Prevailing community standard analysis
• Has the pharmacist kept up with the changes in pharmacy practice and are they competent as evidenced by circumstantial markers….CE, peer‐review, etc
• For Technicians – the Performance Standard
• Shifting task based activities to technicians the assessment becomes• Done or not done
• How is it done: correctly or not
How do Technicians Facilitate the Practice
• Knowledge• General or Core
• System Specific
• Experience
• Licensure• Accountability
• This will require a fundamental shift in how we regulate and how pharmacies manage the workplace
Examples of the change in concept
• Go West – The Village People• (Go west) Life is peaceful there.(Go west) Lots of open air.(Go west) To begin life new.(Go west) This is what we'll do.
• Oregon• During the 2015 Legislative Session, House Bill (HB) 2879 passed into law and was signed by Oregon Governor Kate Brown on July 6, 2015. The law is intended to develop standard procedures for the prescribing of hormonal contraceptive patches and oral contraceptives by an Oregon licensed pharmacist, providing timely access to care.
California
• As of August 10, 2016, pharmacists in California may now seek certification as an Advanced Practice Pharmacist (APP).
• The 2013 bill created the APP designation which is required for community pharmacists to obtain in order to qualify to participate in collaborative practice agreements. The 2013 bill also expanded all pharmacists’ scope of practice by creating statewide protocols under which pharmacists can “furnish” (a.k.a. prescribe) certain products including self administered contraceptives, immunizations, travel medications, smoking cessation therapy and naloxone.
9/1/2017
3
In Health Systems….
• Credentialing • Document and demonstrate that the healthcare professional being evaluated has attained the credentials and qualifications to provide the scope of care expected for patient care services in a particular setting.
• Privileging• Assure stakeholders that the health care professional being considered for certain privileges has the specific competencies and experience for specific services that the organization provides and/or supports.
• http://www.pharmacycredentialing.org/Files/CCP_Special_Feature.pdf
Path Forward
• Create a dual path for the advancement of pharmacist professionally concomitantly with the advancement of opportunity for pharmacy technicians
• Expanded duties for each….as pharmacists duties change the statute and regulations back fill the tasks removed and place within the scope of the pharmacy technician
• Implement changes to definitions and application of supervision
• Use technology to facilitate changes to pharmacist practice and abilities to supervise technician tasks
Alex J. Adams
Pre-Test Questions
True or False:1. Scope of practice is a legal construct that varies state to state.
2. The Idaho Board of Pharmacy has been authorized to create a “behind the counter” class of drugs provided certain conditions are met.
3. In Idaho, a trained and certified technician may administer any vaccine at the discretion of their supervising pharmacist.
MAY CAN
Scope of Practice
• A legal construct in which the activities that a health professional is permitted to engage in are defined by laws and regulations of the state
• Determined by the political process
• Geographical differences; applies to all professionals in class
• Static (aside from law changes)
Clinical Ability
• The true competence and ability of the health professional
• Determined by education, training, career experience, and practice environment
• National education standards; applies to individuals
• Dynamic; advances with new education, accrued experiences, new technology, etc.
MAY CAN
The overarching goal of health professional regulation should be to harmonize clinical ability and scope of practice.
Health Professional Regulation
9/1/2017
4
Precautionary Principle
• The belief that new practices or innovations should be curtailed or disallowed until their proponents can prove that they will not cause harm.
• Fear of worst‐case scenarios• “Mother May I”
Permissionless Innovation
• The belief that experimentation with new technologies and practice models should generally be permitted by default; burden of proof on proving harm
• Allows bottom‐up solutions• Back‐end enforcement
Markers of Progressive Pharmacy PracticeAutonomous Rx Initiation
Drugs that do not require a (new) diagnosis
Drugs for conditions that are minor or self‐limiting
Drugs for conditions that have a CLIA‐waived rapid diagnostic
test
Drugs used in an emergency situation
Collaborative Rx Initiation and/or Adaptation and/or Other Care Services
Patient‐Specific CPA (most restrictive)
Population‐Specific CPA (least restrictive)
Other Care Services
Administer vaccines
Administer other drugs
Order and interpret CLIA‐waived tests
Order and interpret non‐CLIA‐waived tests
Adapting a Rx
Extend a prescription
Make a therapeutic substitution
Change the dosage form
Change the quantity of the prescribed drug
Exercise informed intuition
• Immunizations
• Dietary fluoride supplements
• Opioid antagonists
• Epinephrine auto-injectors
• TB purified protein derivative
• Tobacco cessation medications
Idaho Autonomous Prescriptive Authority
• Drugs, drug categories or devices that are specifically authorized in rules adopted by the Board . . . limited to conditions that:• Do not require a new diagnosis; or
• Are minor and generally self-limiting; or
• Have a CLIA-waived test that is used to guide diagnosis; or
• Threaten the health and safety of the patient should the prescription not be immediately dispensed.
Idaho House Bill 191 (2017)
Technician Activities
Patient Care Activities
• Broad support for expanding the role of appropriately-trainedtechnicians
• Some pharmacists report concerns for their own liability
• Feel that as technician role expands, so should the technician’s own liability
• Pharmacists report variability in technician qualifications for expanded duties
• Critical to ensure assignment of function rests with the pharmacist
• Technicians reflect excitement about new roles and career opportunities
• Express frustration that they’ve “maxed out”
• Appreciate concept of a career ladder
Technician Advanced Roles
9/1/2017
5
Medication Dispensing Support
• Accept a verbal prescription• Clarify technical elements of
prescription• Transfer a prescription• Search PDMP• Perform final verification of
medications that have previously undergone DUR by a pharmacist
Technical Support for Pharmacist Clinical Services
• Administer immunizations• Administer CLIA‐waived tests• Perform basic physical
assessment (e.g., pulse, temperature, blood pressure)
• Conduct medication reconciliation or preparatory work for MTM
Delegated Technician Authority Post-Test Questions
True or False:1. Scope of practice is a legal construct that varies state to state.
2. The Idaho Board of Pharmacy has been authorized to create a “behind the counter” class of drugs provided certain conditions are met.
3. In Idaho, a trained and certified technician may administer any vaccine at the discretion of their supervising pharmacist.
Desi Kotis, Pharm.D., FASHP
Northwestern Medicine VisionOUR VISION:
To be a premier integrated academic health system that will serve a broad community and bring the best in medicine – including breakthrough treatments and clinical trials enhanced through our affiliation with Northwestern University Feinberg School of Medicine – to a growing number of patients close to where
they live and work.
OUR VISION: To be a premier integrated academic health system that will serve a broad community and bring the best in medicine – including breakthrough treatments and clinical trials enhanced through our affiliation with Northwestern University Feinberg School of Medicine – to a growing number of patients close to where
they live and work.
3
Northwestern Medicine Values
PATIENTS FIRST
Putting patients first in all we do
TEAMWORKTeam success over personal success
EXCELLENCEContinuously striving to be
better
INTEGRITYAdhering to an uncompromising code of ethics that
emphasizes complete honesty
and sincerity
4
Three High Level Goals
9/1/2017
6
Advancements in Pharmacy Technician
Pharmacy Technician
Tech‐Check‐Tech
Kit Check
Decentralized Technicians
Patient Care Advocates
Technician Manager
Pharmacy Students
Tech‐Check‐Tech
• Specialized Technician• Technician autonomy
• Expanded role
• Frees up pharmacist to focus on patient care
• Safety and Quality Assurance measures in place
RFID Technology
• Technicians have COMPLETE ownership
• System designed to accurately check trays
• Anesthesia trays
• Emergency crash cart trays
• Uses RFID technology to ensure accuracy of medication
About Kit Check. https://kitcheck.com/about/
Decentralized Technician
• Technician ownership of entire floor
• Faster medication delivery
• Improved nursing and patient satisfaction
Patient Care Advocates
• Script data entry
• Benefits investigation
• Prior authorizations
• Financial assistance• Copay cards• Enrollment in manufacturer assistance programs• Finding funding using grants and other foundation programs
• Facilitating shipment of the drug
• Call center services• Refill management• Facilitate answering questions
Specialty Pharmacy Technicians
Promoting the Profession of Pharmacy• Co‐Funded Faculty
• Train 420 PharmD. students from eight Colleges of Pharmacy
9/1/2017
7
Pharmacy Students
• Integrated Practice Model
• Medication History and Reconciliation
• Drug information and policy
• Drug Shortages
• Flu Vaccine campaign
Practice Advancement Initiative Process
85% of hospitals have pharmacists who have
taken a leadership role in an ASP
60% of hospitals have collaborative practice agreements with
pharmacists and other providers
52% of pharmacy departments evaluated ways to improve the
organization’s effectiveness as an accountable care
organization
67% of hospitals have processes to ensure medication‐related continuity of care
68% of pharmacists in ambulatory care settings follow a standardized patient care process
http://www.ashpmedia.org/pai/docs/PAI‐Progress‐Measures.pdf
Pharmacist Lead Education• Bridge and Transition Team (BAT)
• Interdisciplinary Team
• Pharmacist role is to educate patients
Patient admitted to hospital
flagged as BAT patient
BAT team is consulted
Prior to discharge Pharmacist leads
medication education
Pharmacist Lead Education (cont.)
• Pharmacist centric study conducted
March 2016: BAT Team Initiated
July 2016: Cardiology Pharmacist Education
Initiative
October 2016: Initiative Expands to General Medicine Floors
February 2017: End of Data Analysis
944 BAT patients flagged for pharmacist education
Pharmacist Lead Education (cont.)
30 Day Readmissions
30 DayReadmission Rate
Patients NOT educated by a pharmacist (n=405)
79 19.5
p = 0.017
Patients educated by a pharmacist (n=539)
74 13.7
• Pharmacist education at discharge is associated with decreased 30 day all‐cause readmission rate (19.5% v 13.7 %, p=0.017)
Emergency Department and Response
• Pharmacist Code Response
• GEDI‐WISE Medication History• Includes Pharmacy Students
• Identifies potential medication related ED visits
• Pharmacist Driven Anticoagulation Counseling and Follow‐Up
Northwestern
9/1/2017
8
Organization Quality Metric• Antimicrobial Stewardship
Optimize Antimicrobial Therapy (TJC 6,7,8) FY16 Target Q1 Q2 Q3 Q4
FQ rate of PO utilization 52% 60% 59.1 69.9 73.2
Fluconazole rate of PO utilization 85% 87% 83.8 85.7 87.4
Reduce Incidence of c.diff (TJC 6,7,8) FY16 Target Q1 Q2 Q3 Q4
# positive HO‐C.diff tests (per month) 51 48 42 37 34
C. Diff SIR (quarterly) 1.034 0.93 0.88 0.92 0.9
HO‐C.diff rate/1000 pt days 0.70 0.66 0.58 0.5 0.47
Improve Antibiotic Education(TJC 2,5,6,7, 8) FY16 Target Q1 Q2 Q3 Q4
% appropriate CAP 87% 90% 100 96% 98%
% appropriate UTI 80% 90% 91% 94% 88%
Pharmacy Residency Program
• 10 traditional PGY1 residents
• 4 non‐traditional PGY1 residents
• Critical Care PGY2 resident
• 2 Hematology/Oncology PGY2 residents
• 2 Transplant PGY2 residents
• 1 Health‐System Administration PGY1 resident
• 1 Infectious Diseases PGY2 resident
• 1 Emergency Medicine PGY2 resident
• 2 Ambulatory Care PGY2 residents
• 3 Infectious Diseases Fellows
Part of the graduating residency and fellowship class of June 2017
The Northwestern Pharmacy Department offers a traditional PGY1 program, a non‐traditional PGY1 program, many PGY2 programs, and a fellowship in Infectious Disease.
Residency Growth
6 6
1012
14 14 14
45
4
7
8
1513
0
5
10
15
20
25
30
35
2011‐2012 2012‐2013 2013‐2014 2014‐2015 2015‐2016 2016‐2017 2017‐2018
Residency Growth By Year
Number of PGY1s Number of PGY2s and Fellows
300%
Advancing Medical Science and Knowledge
Note: Presentations includes presentations, posters, workshops, case studies, and panel discussions.
28 47 53 56 75 86 86 82 852321 24 29
3550 60
40 48
2733 31
4646
49 5060
69
0
50
100
150
200
250
2008 2009 2010 2011 2012 2013 2014 2015 2016
PHARMACY: Publication, Presentation and Research Activity
Presentation Publication Research Studies
300%
Advancing Medical Science and KnowledgeRecent Publications
Miglis, C., Rhodes, N., Avedissian, S., Zembower, T., Postelnick, M., Wunderink, R., . . . Scheetz, M. A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and Underutilization. Infection Control & Hospital Epidemiology, 2017, 38(7), 860‐862.
Miglis C, Rhodes NJ, Kuti JL, Nicolau DP, Van Wart SA, Scheetz MH. Defining the impact of severity of illness on time above the MIC threshold for cefepime in gram‐negative bacteremia: a 'goldilocks' window. Int J Antimicrob Agents. 2017 Jun 28. pii: S0924‐8579(17)30237‐6. doi: 10.1016/j.ijantimicag.2017.04.023. [Epub ahead of print] PubMed PMID: 28668683.
Gilbert EM, Zembower TR, Rhodes NJ, Qi C, Reiner S, Malczynski M, Scheetz MH. Factors contributing to vancomycin‐resistant Enterococcus spp. Horizontal transmission events: exploration of the role of antibacterial consumption. Diagn Microbiol Infect Dis. 2017 Jun 2. pii: S0732‐8893(17)30174‐8. doi: 10.1016/j.diagmicrobio.2017.05.014. [Epub ahead of print] PubMed PMID: 28669681.
Rhodes NJ, Grove ME, Kiel PJ, O'Donnell JN, Whited LK, Rose DT, Jones DR, Scheetz MH. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose‐dependent susceptibility and contemporary dosing regimens. Int J Antimicrob Agents. 2017 Jun 28. pii: S0924‐8579(17)30200‐5. doi: 10.1016/j.ijantimicag.2017.04.008. [Epub ahead of print] PubMed PMID: 28668694.
Rhodes, N., Gilbert, E., Skoglund, E., Esterly, J., Postelnick, M., McLaughlin, M. Prediction of inventory sustainability during a drug shortage. American Journal of Health‐System Pharmacy Jul 2016, 73 (14) 1094‐1098; DOI: 10.2146/ajhp150532
Watson WA, Rhodes NJ, Echenique IA, Angarone MP, Scheetz MH. Resolution of acyclovir‐associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature. J Clin Pharm Ther. 2017 Jun;42(3):350‐355. doi: 10.1111/jcpt.12520. Epub 2017 Mar 29. PubMed PMID: 28370067; PubMed Central PMCID: PMC5404941
Scheetz MH, Crew PE, Miglis C, et al. Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework. Antimicrobial Agents and Chemotherapy. 2016;60(6):3265‐3269. doi:10.1128/AAC.00572‐16.
Maas MB, Francis BA, Sangha RS, Lizza BD, Liotta E, M, Naidech A, M, Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment. Cerebrovasc Dis 2017;43:110‐116
Rhodes NJ, Wagner JL, Gilbert EM, Crew PE, Davis SL, Scheetz MH. Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics. Infect Control Hosp Epidemiol. 2016 Aug;37(8):971‐3. doi: 10.1017/ice.2016.109. Epub 2016 May 13. PubMed PMID: 27174570.
Lizza BD, Rhodes NJ, Esterly JS, Scheetz MH, Impact of body mass index on clinical outcomes in patients with gram‐negative bacteria bloodstream infections, Journal of Infection and Chemotherapy, Volume 22, Issue 10, 2016, Pages 671‐676, ISSN 1341‐321X,
E. M. Liotta, B. D. Lizza, A. L. Romanova et al., “23.4% Saline decreases brain tissue volume in severe hepatic encephalopathy as assessed by a quantitative CT marker,” Critical Care Medicine, vol. 44, no. 1, pp. 171–179, 2016
Ellinger LK. Research study design. In: Gabay M, ed. The Clinical Practice of Drug Information. Burlington, MA: Jones & Bartlett Learning; 2016:125‐137.
Phatak A, Prusi R, Ward B, Hansen LO, Williams MV, Vetter E, Chapman N, Postelnick M, Pharmacist Impact on Transitional Care. J. Hosp. Med2016;1;39‐44. doi:10.1002/jhm.2493
Prothrombin Complex Concentrate Reduces Intraoperative Blood Product Utilization in Heart Transplantation, Enter, D. Marsh, M, Melody, N et al. The Journal of Heart and Lung Transplantation , 2017, Volume 35 , Issue 4 , S293
Chapter 7: Research Study Design, Lara Ellinger
Changing Health OutcomesAmbulatory Care
Patients First
• Integrated specialty medication management (Available 24/7)
• Navigation of patients through the complex process
• Smooth transitions in care (Medication to bedside prior to discharge)
Safety Always
• Work alongside care team to ensure safe medication use
• Side effects are minimized and managed appropriately
• Patients receive education and follow up monitoring
Financial Stewardship
• Generate financial resources (profit margin)
• Optimize care and outcomes
• Strategic positioning for ACO model
Exceptional Patient Experience
9/1/2017
9
Ambulatory Care Patients Achieve Desired Outcomes
September 2015 through August 2016
• 396 total patients received therapy management at NM• 261 completed therapy
• HCV RNA undetectable lab results
• 96% ‐ Cure rate for patients who receive therapy management
• 11 patients have shown HCV RNA detectable lab results at the end of therapy
• Complex transplant or co‐infected patients
• 124 remaining are completing therapy• Projecting undetectable HCV RNA according to most recent lab test
Hepatitis C Clinical Outcomes
50
Questions?